The increase in price target by a reputable analyst firm like Cantor Fitzgerald typically signals a strong bullish sentiment towards the company's stock. This adjustment reflects positive expectations for Mirum Pharmaceuticals' performance, likely based on the company's recent developments, financial health, or market position. Such endorsements can lead to increased investor confidence and potentially drive the stock price up in the short term.